Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LARGE antisense RNA 1 (LARGE-AS1) is a long non-coding RNA transcribed antisense to the LARGE gene locus. Like other antisense lncRNAs, it cannot be translated into protein and instead functions predominantly by regulating the expression of its corresponding sense gene or nearby loci. Mechanisms may involve RNA-RNA complementarity, modulation of transcriptional activity, or interaction with chromatin remodeling complexes. While antisense RNAs broadly have roles in gene regulation, chromatin remodeling, and are sometimes implicated in disease processes such as cancer, there is currently no disease association or therapeutic application directly attributed to LARGE-AS1. This molecule is part of the rapidly expanding set of lncRNAs with potential as future therapeutic targets, research tools, or biomarkers, but detailed functional characterization is lacking in published literature[1][5].
None identified specifically for this molecule. In general, antisense RNA can regulate gene expression via sequence-dependent interaction (RNA-RNA, RNA-DNA, RNA-protein), transcriptional interference, or recruitment of chromatin modifiers
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LARGE antisense RNA 1 (LARGE-AS1).